BOTOX Prophylaxis in Patients With Chronic Migraine
Phase of Trial: Phase IV
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Migraine
- Focus Adverse reactions
- Sponsors Allergan
- 27 Jun 2017 Results (n=1160) presented at the 3rd Congress of the European Academy of Neurology.
- 21 Apr 2016 Results of an Interim Analysis presented at the 68th Annual Meeting of the American Academy of Neurology
- 13 May 2015 Planned End Date changed from 1 May 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.